Table 3 Fibroscan results pre and post-surgery.

From: Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery

Fibroscan data

Baseline (n = 70)

Follow-up (n = 70)

p value

Mean CAP Steatosis (dB/m)

301.9 (± 52.9)

234.9 (± 53.0)

 < 0.001

 Significant steatosis (≥ 248 dB/m)

61 (87%)

24 (34%)

 < 0.001

 Severe steatosis (≥ 320 dB/m)

24 (34%)

5 (7%)

 < 0.001

Mean LSM Fibrosis (kPa)

5.3 (± 1.9)

4.4 (± 1.2)

 < 0.001

 Significant fibrosis (> 8.2 kPa)

5 (7%)

0

 < 0.05

 Advanced fibrosis (> 9.6 kPa)

4 (6%)

0

NS

Back to article page